TSH Biopharm Corporation Limited (8432.TWO)

TWD 47.5

(-1.04%)

EBITDA Summary of TSH Biopharm Corporation Limited

  • TSH Biopharm Corporation Limited's latest annual EBITDA in 2023 was 99.35 Million TWD , down -8.53% from previous year.
  • TSH Biopharm Corporation Limited's latest quarterly EBITDA in 2024 Q1 was 51.26 Million TWD , up 70.33% from previous quarter.
  • TSH Biopharm Corporation Limited reported an annual EBITDA of 106.5 Million TWD in 2022, up 49.35% from previous year.
  • TSH Biopharm Corporation Limited reported an annual EBITDA of 71.31 Million TWD in 2021, down -17.85% from previous year.
  • TSH Biopharm Corporation Limited reported a quarterly EBITDA of 34.67 Million TWD for 2024 Q2, down -32.36% from previous quarter.
  • TSH Biopharm Corporation Limited reported a quarterly EBITDA of 30.09 Million TWD for 2023 Q4, up 24.02% from previous quarter.

Annual EBITDA Chart of TSH Biopharm Corporation Limited (2023 - 2019)

Historical Annual EBITDA of TSH Biopharm Corporation Limited (2023 - 2019)

Year EBITDA EBITDA Growth
2023 99.35 Million TWD -8.53%
2022 106.5 Million TWD 49.35%
2021 71.31 Million TWD -17.85%
2020 86.8 Million TWD -23.21%
2019 113.04 Million TWD 0.0%

Peer EBITDA Comparison of TSH Biopharm Corporation Limited

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD 51.487%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD 57.009%
Easywell Biomedicals, Inc. -85.5 Million TWD 216.197%
TTY Biopharm Company Limited 1.52 Billion TWD 93.483%
Synmosa Biopharma Corporation 1 Billion TWD 90.151%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 82.957%
Center Laboratories, Inc. -175.17 Million TWD 156.716%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD -219.988%
Orient Pharma Co., Ltd. 172.39 Million TWD 42.371%
InnoPharmax Inc. -62.12 Million TWD 259.932%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD 21.573%
Excelsior Biopharma Inc. -29.36 Million TWD 438.282%
DV Biomed Co., Ltd. 407.64 Million TWD 75.628%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 110.892%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 87.624%
UniPharma Co., Ltd. -16.25 Million TWD 711.234%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD 24.339%
Alar Pharmaceuticals Inc. 394.52 Million TWD 74.817%
Winston Medical Supply Co., Ltd. 228.32 Million TWD 56.487%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 354.522%
Bioray Biotech Co., Ltd 12.13 Million TWD -718.706%